AGM/EGMJun 4, 2026, 04:32 PM
Can-Fite BioPharma Shareholders Approve All Proposals at AGM
AI Summary
Can-Fite BioPharma Ltd. announced that its Annual General Meeting of Shareholders, held on June 4, 2026, successfully approved all five proposals presented. These proposals were detailed in the company's Notice and Proxy Statement, which was furnished to the SEC on April 23, 2026.
Key Highlights
- Can-Fite BioPharma shareholders approved all five proposals at the Annual General Meeting.
- Proposals were described in the Notice and Proxy Statement dated April 23, 2026.
Price Impact
More from CANF